Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
Suffering from dry skin during cold, winter days? Experts share tips on what to do and what not to do when managing dry skin ...
GlobalData on MSN17h
FDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
An itch so intense it disrupts sleep, accompanied by small, red rashes that spread across the body, is the daily reality for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback